Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000689036 | SCV000816672 | benign | Autosomal dominant nonsyndromic hearing loss 1; Progressive microcephaly-seizures-cortical blindness-developmental delay syndrome | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001653979 | SCV001870920 | benign | not provided | 2021-04-15 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002544839 | SCV003682119 | likely benign | Inborn genetic diseases | 2022-06-03 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV001653979 | SCV004157241 | likely benign | not provided | 2022-07-01 | criteria provided, single submitter | clinical testing | DIAPH1: BS2 |